Ecaranum, Rhaine Gazelle R.
HRN: 20-93-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2024
CEFUROXIME 750MG (VIAL)
12/25/2024
12/31/2024
IV
500 Mg
Q8H
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes